Rituximab, an Anti‐CD20 Monoclonal Antibody: History and Mechanism of Action - Pescovitz - 2006 - American Journal of Transplantation - Wiley Online Library
Anti-CD20 Antibody Therapy for B-Cell Lymphomas | NEJM
Rituximab in dermatology | Actas Dermo-Sifiliográficas
Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance | Oncogene
Treatment of non-Hodgkin Lymphomas - ppt video online download
Overcoming rituximab drug-resistance by the genetically engineered anti-CD20-hIFN-α fusion protein: Direct cytotoxicity and synergy with chemotherapy
A review of the current use of rituximab in autoimmune diseases - ScienceDirect
Anti-CD20 Antibodies for Idiopathic Nephrotic Syndrome in Children | American Society of Nephrology
Rituximab: modes of action, remaining dispute and future perspective | Future Oncology
Rituximab - Wikipedia
How the discovery of rituximab impacted the treatment of B-cell non-Ho | JBM
Rituximab mode of action: apoptosis and ADCC. Rituximab mediated... | Download Scientific Diagram
Rituximab mode of action.
Rituximab, an Anti‐CD20 Monoclonal Antibody: History and Mechanism of Action - Pescovitz - 2006 - American Journal of Transplantation - Wiley Online Library
Lymphoid Malignancies (LGBLM) - ppt download
Summary of mechanisms that influence rituximab efficiency. These... | Download Scientific Diagram
Rituximab: Mechanism of Action - ScienceDirect
Rituximab | Immunopaedia
Drug Insight: the mechanism of action of rituximab in autoimmune disease—the immune complex decoy hypothesis | Nature Reviews Rheumatology
Rituximab - Wikipedia
Rituximab therapy in nephrotic syndrome: implications for patients' management | Nature Reviews Nephrology
Rituximab mode of action: apoptosis and ADCC. Rituximab mediated... | Download Scientific Diagram
